Investors Weigh Risks as Bristol Myers Squibb Shares Face Significant Market Pressure
The pharmaceutical landscape is currently witnessing a period of profound transition, and few companies embody this shift more than Bristol Myers Squibb.
by 
Josh Weiner
Josh Weiner